FDA data Registry peer set 1 peer

Alternatives to rasagiline

1 same-class SPL records vs rasagiline - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

View rasagiline → All alternatives

Brand: Azilect

MAO-B Inhibitor Prescription 1 alternative found

About rasagiline

Rasagiline (Azilect) is a medicine used to treat Parkinson's disease. It helps to improve motor control and reduce symptoms like tremors and stiffness.

Used for: Rasagiline is used to treat Parkinson's disease. Parkinson's disease is a brain disorder that affects movement. This medicine can be used alone or with other Parkinson's medicines to help control your symptoms.

View full rasagiline profile →

1 MAO-B Inhibitor peers (wide set)

safinamide

Rx

Xadago

Safinamide is used to treat Parkinson's disease. It is for people who take levodopa/carbidopa but still have "off" times. During these times, Parkinson's symptoms like stiffness and slow movement come back.

Compare rasagiline vs safinamide side-by-side →

rasagiline vs safinamide · FAERS reaction fields

FAERS top-reaction field "Fall" shows the widest count spread between rasagiline and safinamide in this extract (189-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect rasagiline safinamide
Fall 343 154
Hallucination 326 142
Dyskinesia 276 137
Parkinson^S Disease 216 89
Dizziness 205 56
Tremor 204 81
Death 200 90
Confusional State 178 53

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

rasagiline peer mix vs class inventory

Peer mix

0 OTC and 1 Rx SPL records in this peer set (1 total). Class inventory for MAO-B Inhibitor: 2 drugs.

Frequently Asked Questions

What same-class SPL records sit beside rasagiline? ▼
This registry lists 1 MAO-B Inhibitor medication records beside rasagiline, including safinamide. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide MAO-B Inhibitor peer set (1 records)

rasagiline (Azilect) sits in a wide MAO-B Inhibitor peer set (1 of 1 class peers shown). Labeled indication field for rasagiline: Rasagiline is used to treat Parkinson's disease.

Top FAERS reaction fields for rasagiline total 2,272 reports across 10 reactions, set beside safinamide. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full rasagiline profile →

Field note for rasagiline: see also the generic vs brand label guide when reading Azilect SPL strings.

Read our methodology - how this data is sourced, computed, and verified.